Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03821051

China Structural Ventricular Arrhythmias Registry

China Structural Ventricular Arrhythmias Registry, a Multicenter,Observational and Prospective Study.

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
China National Center for Cardiovascular Diseases · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is an observational, prospective, multi-center registry ,aiming at building a risk stratification for malignant structural ventricular arrhythmias. 2000 participants will be recruited from 10 centers in China,with clinical data to be abstracted from medical records ,and blood samples to be collected for finding promising risk indicators.The follow-up should be made every 6 mouths.

Detailed description

In China, the prevalence and risk factors of malignant ventricular arrhythmias remain unclear. In addition ,the mainstream treatment relies on implantable devices and medication.China Malignant Ventricular Arrhythmias Study is a nation-wide complex consisting of several interrelated studies, with the aim of building a risk stratification as well as a efficient and economic strategy for early prevention and treatment. Structural Ventricular Arrhythmias Registry, as a part of China Malignant Ventricular Arrhythmias Study, is an observational, prospective, multi-center registry, aiming at building a risk stratification for malignant structural ventricular arrhythmias. 2000 patients with definitive diagnosis will be recruited consecutively from 10 major arrhythmia centers distributed in 6 areas in China. At study entry, participants will be interviewed and asked to sign the informed consent. Demographic characteristics, medical history, clinical features, laboratory tests, imaging pictures, medications, procedures, and in-hospital outcomes of patients will be abstracted from medical records by well trained staffs .At the same time, blood samples will be collected to detect biological markers, like genes, inflammatory factors ,etc. Once enrolled, the participants will receive follow up every 6 mouths about condition of arrhythmia, medication, clinical events, etc.

Conditions

Timeline

Start date
2017-10-24
Primary completion
2022-10-24
Completion
2027-10-24
First posted
2019-01-29
Last updated
2019-01-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03821051. Inclusion in this directory is not an endorsement.